✨
AI Summary
- NodThera develops brain-penetrant NLRP3 inflammasome inhibitors.
- Focus on chronic inflammatory diseases and obesity.
- Pipeline and recent data on Parkinson's disease.
Guests on This Episode
AW
Alan Watt
1 podcast appearance